D
45
-5
CNX
44
-2
TRV
56
-2
AN
54
-4
BDX
52
-3
ROST
66
-2
KIM
53
-4
WEC
50
-5
TSN
52
-4
KMX
55
-2
IVZ
63
-2
FLS
48
-2
SYK
35
-2
NI
63
-4
HRL
36
-5
ED
37
-3
NWS
64
2
EMC
47
-5
CRM
39
-3
WFC
58
4
D
45
-5
CNX
44
-2
TRV
56
-2
AN
54
-4
BDX
52
-3
ROST
66
-2
KIM
53
-4
WEC
50
-5
TSN
52
-4
KMX
55
-2
IVZ
63
-2
FLS
48
-2
SYK
35
-2
NI
63
-4
HRL
36
-5
ED
37
-3
NWS
64
2
EMC
47
-5
CRM
39
-3
WFC
58
4
Financhill
Back

Greek Organisation Of Football Prognostics S.A. - ADR Vs. Akero Therapeutics Industry Stock Comparison

Buy
63

GOFPY
Greek Organisation Of Football Prognostics S.A. - ADR

Last Price:
$11.63
Seasonality Move:
-0.07%
Sell
46

AKRO
Akero Therapeutics

Last Price:
$49.43
Seasonality Move:
26.87%
Buy
63
Greek Organisation Of Football Prognostics S.A. - ADR (GOFPY) is a Buy

Is Greek Organisation Of Football Prognostics S.A. - ADR a Buy, Sell or Hold?

  • The current Greek Organisation Of Football Prognostics S.A. - ADR [GOFPY] share price is $11.58. The Score for GOFPY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GOFPY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $50.09. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOFPY Stock Price Chart

What is Greek Organisation Of Football Prognostics S.A. - ADR's stock price today?

  • The Greek Organisation Of Football Prognostics S.A. - ADR share price today is $11.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $50.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GOFPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.97 Buy
Relative Strength Index (14 RSI): 56.01 Buy
Chaikin Money Flow: 26280 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.07 - 11.57) Buy
Bollinger Bands (100): (10.46 - 11.58) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 49.73 Sell
Chaikin Money Flow: 1066365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.52 - 52.32) Sell
Bollinger Bands (100): (40.84 - 53.12) Buy

GOFPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.6 Sell
20-day SMA: 11.3 Buy
50-day SMA: 11.26 Buy
200-day SMA: 9.76 Buy
8-day EMA: 11.14 Buy
20-day EMA: 8.36 Buy
50-day EMA: 4.64 Buy
200-day EMA: 1.39 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.75 Buy
20-day SMA: 49.82 Buy
50-day SMA: 52.04 Sell
200-day SMA: 41.79 Buy
8-day EMA: 49.35 Buy
20-day EMA: 49.93 Buy
50-day EMA: 49.95 Buy
200-day EMA: 42.97 Buy

Greek Organisation Of Football Prognostics S.A. - ADR Earnings Growth & GOFPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.

Greek Organisation Of Football Prognostics S.A. - ADR Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):